[1] ZHANG YF, SHEN S, SHI JM, et al.Isolation, characterization, and phylogenic analysis of three new severe fever with thrombocytopenia syndrome bunyavirus strains derived from Hubei Province, China[J]. Virol Sin, 2017, 32(1): 89-96. [2] JO YS, KANG JG, CHAE JB, et al.Prevalence of severe fever with thrombocytopenia syndrome virus in ticks collected from national parks in Korea[J]. Vector Borne Zoonotic Dis, 2019, 19(4): 284-289. [3] ZHAN J, WANG Q, CHENG J, et al.Current status of severe fever with thtombocytopenia syndrome in China[J]. Virol Sin, 2017, 32(1): 51-62. [4] 施泽纶,乾虎,马世良,等.新型布尼亚病毒病原学和诊断学进展[J/CD].新发传染病电子杂志,2018,3(3):140-142. [5] 肖玲燕,史东阳,刘永福,等. 重症新型布尼亚病毒感染的临床特征和疗效分析[J/CD].新发传染病电子杂志,2020,5(1):16-19. [6] 韩常新,孙艾军,蒲春文,等. 新型布尼亚病毒感染致发热伴血小板减少综合征的流行病学特征及预后影响指标分析[J]. 中华医院感染学杂志,2019,29(2):171-174. [7] 周忠进,左文涛. 发热伴血小板减少综合征患者的临床特点与预后分析[J/CD].中西医结合心血管病电子杂志,2020,83(6):1-7. [8] LI MM, ZHANG WJ, WENG XF, et al.CD4 T cell loss and Th2 and Th17 bias are associated with the severity of severe fever with thrombocytopenia syndrome (SFTS)[J]. Clin Immunol, 2018, 195: 8-17. [9] ZHANG LK, WANG B, XIN Q, et al.Quantitative proteomic analysis reveals unfolded-protein response involved in severe fever with thrombocytopenia syndrome virus infection[J]. J Virol , 2019, 93(10): 308-319. [10] 黄惠榕,刘秦宇,韩雪琪,等.基于CiteSpace的国内外科护理教学模式的视化分析[J].医学理论与实践,2020,33(11):1742-1745. [11] 丛丽娴. 90例发热伴血小板减少综合征多器官损害临床分析[J].传染病信息,2018,31(1):79-82. [12] YU XJ, LIANG MF, ZHANG SY, et al.Fever with thrombocytopenia associated with a novel bunyavirus in China[J]. N Engl J Med , 2011, 364(16): 1523-1532. [13] 卫生部. 卫生部发布《发热伴血小板减少综合征防治指南(2010版)》[J].中国药房,2010,21(42):3990-3990. [14] 叶继斌. 发热伴血小板减少综合征2011专家共识侧记[J/CD].中华实验和临床感染病杂志(电子版),2012,6(4):356-357. [15] 中国中西医结合学会传染病专业委员会.发热伴血小板减少综合征中西医结合诊疗专家共识[J].环球中医药,2019,12(10):1506-1511. [16] 李昱,周航,牟笛,等.中国2011-2014年发热伴血小板减少综合征流行特征分析[J].中华流行病学杂志,2015,36(6):598-602. [17] LIU Q, HE B, HUANG SY, et al.Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis[J]. Lancet Infect Dis, 2014, 14(8): 763-772. [18] CHAUDHARY V, ZHANG S, YUEN KS, et al.Suppression of type I and type III IFN signalling by NSs protein of severe fever with thrombocytopenia syndrome virus through inhibition of STAT1 phosphorylation and activation[J]. J Gen Virol, 2015, 96(11): 3204-3211. [19] NING YJ, FENG K, MIN YQ, et al.Disruption of type I infection signalling by the nonstructural protein of severe fever with thrombocytopenia syndrome virus via the hijacking of STAT2 and STAT1 into inclusion bodies[J]. J Virol Methods, 2015, 89(8): 4227-4236. [20] HE CQ, DING NZ.Discovery of severe fever with thrombocytopenia syndrome bunyavirus strains originating from intragenic recombination[J]. J Virol , 2012, 86(22): 12426-12430. [21] 刘硕,徐东强,于成勇,等.实验室检查指标对发热伴血小板减少综合征的早期诊断及预后的影响[J].中华传染病杂志,2020,38(4):245-248. [22] 张鸿雁,陈桂榴,李文庭,等. 不同预后的发热伴血小板减少综合征重症患者临床实验室指标对比分析[J].中华疾病控制杂志,2020,24(3):356-358. [23] YUN S, LEE W, RYOU J, et al.Severe fever with thrombocytopenia syndrome virus in ticks collected from humans, South Korea, 2013[J]. Emerg Infect Dis, 2014, 20(8): 1358-1361. [24] 马改霞,郭晓燕,张少言,等.发热伴血小板减少综合征患者临床特征的系统分析[J].中华传染病杂志,2020,38(7):432-436. [25] 马于琪,梁明明,尹华发.新型布尼亚病毒感染的临床特征及预后影响因素分析[J].实用医学杂志,2020,36(23):3231-3236. [26] 沈璐梦,俞怡,王叶飞,等.循证护理在新型布尼亚病毒感染病房管理中的应用[J].护理与康复,2017,16(11):1211-1212. [27] 陈秋菊,陈斐,黄倩,等.运用团队资源管理模式提升新型布尼亚病毒感染患者急救品质[J].护理学报,2020,27(2):16-20. [28] 周伟,张伟,王汝刚,等.人感染新型布尼亚病毒病中医临床特征分析[J].国际医药卫生导报,2019,25(8):1268-1270. [29] 周诗君,夏国美,贺腾飞,等.新型布尼亚病毒感染患者临床特征及其预后因素分析[J].安徽医科大学学报,2021,56(6):942-947. [30] 夏国美. 建立发热伴血小板减少综合征患者预后预测模型及治疗方案评估[D].合肥:安徽医科大学,2020. |